Cargando…

Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study

BACKGROUND: The national response to COVID-19 has had a significant impact on cancer services. This study investigated the effect of national lockdown on diagnosis, management, and outcomes of patients with oesophagogastric cancers in Scotland. METHODS: This retrospective cohort study included conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxter, Mark A, Khan, Khurram S, Gall, Lewis S, Samuelson, Catherine, McCollum, Catherine, Chuntamongkol, Rongkagorn, Narramneni, Lakshmi R, Al-Zuabi, Manaf, Bryce, Gavin, Shareef, Hala E J, Forshaw, Matthew, Petty, Russell D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364509/
https://www.ncbi.nlm.nih.gov/pubmed/36810797
http://dx.doi.org/10.1093/bjs/znad003
_version_ 1785076858730053632
author Baxter, Mark A
Khan, Khurram S
Gall, Lewis S
Samuelson, Catherine
McCollum, Catherine
Chuntamongkol, Rongkagorn
Narramneni, Lakshmi R
Al-Zuabi, Manaf
Bryce, Gavin
Shareef, Hala E J
Forshaw, Matthew
Petty, Russell D
author_facet Baxter, Mark A
Khan, Khurram S
Gall, Lewis S
Samuelson, Catherine
McCollum, Catherine
Chuntamongkol, Rongkagorn
Narramneni, Lakshmi R
Al-Zuabi, Manaf
Bryce, Gavin
Shareef, Hala E J
Forshaw, Matthew
Petty, Russell D
author_sort Baxter, Mark A
collection PubMed
description BACKGROUND: The national response to COVID-19 has had a significant impact on cancer services. This study investigated the effect of national lockdown on diagnosis, management, and outcomes of patients with oesophagogastric cancers in Scotland. METHODS: This retrospective cohort study included consecutive new patients presenting to regional oesophagogastric cancer multidisciplinary teams in National Health Service Scotland between October 2019 and September 2020. The study interval was divided into before and after lockdown, based on the first UK national lockdown. Electronic health records were reviewed and results compared. RESULTS: Some 958 patients with biopsy-proven oesophagogastric cancer in 3 cancer networks were included: 506 (52.8 per cent) before and 452 (47.2 per cent) after lockdown. Median age was 72 (range 25–95) years and 630 patients (65.7 per cent) were men. There were 693 oesophageal (72.3 per cent) and 265 gastric (27.7 per cent) cancers. Median time to gastroscopy was 15 (range 0–337) days before versus 19 (0–261) days after lockdown (P < 0.001). Patients were more likely to present as an emergency after lockdown (8.5 per cent before versus 12.4 per cent after lockdown; P = 0.005), had poorer Eastern Cooperative Oncology group performance status, were more symptomatic, and presented with a higher stage of disease (stage IV: 49.8 per cent before versus 58.8 per cent after lockdown; P = 0.04). There was a shift to treatment with non-curative intent (64.6 per cent before versus 77.4 per cent after lockdown; P < 0.001). Median overall survival was 9.9 (95 per cent c.i. 8.7 to 11.4) months before and 6.9 (5.9 to 8.3) months after lockdown (HR 1.26, 95 per cent c.i. 1.09 to 1.46; P = 0.002). CONCLUSION: This national study has highlighted the adverse impact of COVID-19 on oesophagogastric cancer outcomes in Scotland. Patients presented with more advanced disease and a shift towards treatment with non-curative intent was observed, with a subsequent negative impact on overall survival.
format Online
Article
Text
id pubmed-10364509
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103645092023-07-31 Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study Baxter, Mark A Khan, Khurram S Gall, Lewis S Samuelson, Catherine McCollum, Catherine Chuntamongkol, Rongkagorn Narramneni, Lakshmi R Al-Zuabi, Manaf Bryce, Gavin Shareef, Hala E J Forshaw, Matthew Petty, Russell D Br J Surg Original Article BACKGROUND: The national response to COVID-19 has had a significant impact on cancer services. This study investigated the effect of national lockdown on diagnosis, management, and outcomes of patients with oesophagogastric cancers in Scotland. METHODS: This retrospective cohort study included consecutive new patients presenting to regional oesophagogastric cancer multidisciplinary teams in National Health Service Scotland between October 2019 and September 2020. The study interval was divided into before and after lockdown, based on the first UK national lockdown. Electronic health records were reviewed and results compared. RESULTS: Some 958 patients with biopsy-proven oesophagogastric cancer in 3 cancer networks were included: 506 (52.8 per cent) before and 452 (47.2 per cent) after lockdown. Median age was 72 (range 25–95) years and 630 patients (65.7 per cent) were men. There were 693 oesophageal (72.3 per cent) and 265 gastric (27.7 per cent) cancers. Median time to gastroscopy was 15 (range 0–337) days before versus 19 (0–261) days after lockdown (P < 0.001). Patients were more likely to present as an emergency after lockdown (8.5 per cent before versus 12.4 per cent after lockdown; P = 0.005), had poorer Eastern Cooperative Oncology group performance status, were more symptomatic, and presented with a higher stage of disease (stage IV: 49.8 per cent before versus 58.8 per cent after lockdown; P = 0.04). There was a shift to treatment with non-curative intent (64.6 per cent before versus 77.4 per cent after lockdown; P < 0.001). Median overall survival was 9.9 (95 per cent c.i. 8.7 to 11.4) months before and 6.9 (5.9 to 8.3) months after lockdown (HR 1.26, 95 per cent c.i. 1.09 to 1.46; P = 0.002). CONCLUSION: This national study has highlighted the adverse impact of COVID-19 on oesophagogastric cancer outcomes in Scotland. Patients presented with more advanced disease and a shift towards treatment with non-curative intent was observed, with a subsequent negative impact on overall survival. Oxford University Press 2023-02-22 /pmc/articles/PMC10364509/ /pubmed/36810797 http://dx.doi.org/10.1093/bjs/znad003 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Baxter, Mark A
Khan, Khurram S
Gall, Lewis S
Samuelson, Catherine
McCollum, Catherine
Chuntamongkol, Rongkagorn
Narramneni, Lakshmi R
Al-Zuabi, Manaf
Bryce, Gavin
Shareef, Hala E J
Forshaw, Matthew
Petty, Russell D
Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
title Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
title_full Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
title_fullStr Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
title_full_unstemmed Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
title_short Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
title_sort diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the covid-19 pandemic: national study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364509/
https://www.ncbi.nlm.nih.gov/pubmed/36810797
http://dx.doi.org/10.1093/bjs/znad003
work_keys_str_mv AT baxtermarka diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT khankhurrams diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT galllewiss diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT samuelsoncatherine diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT mccollumcatherine diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT chuntamongkolrongkagorn diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT narramnenilakshmir diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT alzuabimanaf diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT brycegavin diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT shareefhalaej diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT forshawmatthew diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy
AT pettyrusselld diagnosistreatmentandoutcomeofpatientswithoesophagogastriccancerduringthecovid19pandemicnationalstudy